- Home
- IGC vs HOOK Comparison
IGC vs HOOK Comparison
Compare IGC & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- HOOK
- Stock Information
- Founded
- IGC 2005
- HOOK 2011
- Country
- IGC United States
- HOOK United States
- Employees
- IGC N/A
- HOOK N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- IGC Health Care
- HOOK Health Care
- Exchange
- IGC Nasdaq
- HOOK Nasdaq
- Market Cap
- IGC 18.0M
- HOOK 18.1M
- IPO Year
- IGC N/A
- HOOK 2019
- Fundamental
- Price
- IGC $0.28
- HOOK $0.77
- Analyst Decision
- IGC Strong Buy
- HOOK Buy
- Analyst Count
- IGC 2
- HOOK 4
- Target Price
- IGC $3.88
- HOOK $10.67
- AVG Volume (30 Days)
- IGC 241.5K
- HOOK 38.9K
- Earning Date
- IGC 02-18-2025
- HOOK 05-08-2025
- Dividend Yield
- IGC N/A
- HOOK N/A
- EPS Growth
- IGC N/A
- HOOK N/A
- EPS
- IGC N/A
- HOOK N/A
- Revenue
- IGC $1,236,000.00
- HOOK $43,946,000.00
- Revenue This Year
- IGC N/A
- HOOK N/A
- Revenue Next Year
- IGC $18.34
- HOOK N/A
- P/E Ratio
- IGC N/A
- HOOK N/A
- Revenue Growth
- IGC 1.65
- HOOK 118.32
- 52 Week Low
- IGC $0.25
- HOOK $0.72
- 52 Week High
- IGC $0.66
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- IGC 45.11
- HOOK 25.98
- Support Level
- IGC $0.25
- HOOK $0.73
- Resistance Level
- IGC $0.29
- HOOK $0.86
- Average True Range (ATR)
- IGC 0.02
- HOOK 0.09
- MACD
- IGC 0.00
- HOOK 0.01
- Stochastic Oscillator
- IGC 60.00
- HOOK 11.58
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.